Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial

Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial

Abstract Background Lumbrokinase has been widely used for patients with acute ischemic stroke (AIS) in China; however, because rigorously designed studies are lacking, safety and efficacy of lumbrokinase in the treatment of acute ischemic stroke remains largely unknown. In this multicenter, randomiz...

Full description

Bibliographic Details
Main Authors: Ying Chen, Yan Liu, Jingjing Zhang, Kehua Zhou, Xuecheng Zhang, Hengheng Dai, Baolin Yang, Hongcai Shang
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Trials
Subjects:
Lumbrokinase
Aspirin
Acute ischemic stroke
Multicenter randomized controlled trial
Trial protocol
Online Access:https://doi.org/10.1186/s13063-022-06200-4

Internet

https://doi.org/10.1186/s13063-022-06200-4

Similar Items